SMARCD1 and neoplasm: More concretely, the N-terminal residues of Smarcd1 could bind with the tetramerization domain of P53, and in LNCaP cell line, knockdown of Smarcd1 suppressed the transcriptional ability of P53, resulting in reduced P53-dependent tumor apoptosis [6].